DE:8VP1 Stock Latest News
Company AnnouncementsAvricore’s HealthTab Links AI Retinal Screening to U.K. Community Pharmacies3w ago
Company AnnouncementsAvricore’s HealthTab Strikes Multi-Year UK Point-of-Care Testing Deal with Abbott1M ago6K
Company AnnouncementsAvricore’s HealthTab Wins National NHS Role in England’s Pharmacy Cholesterol Drive2M ago
Company AnnouncementsAvricore Grants Stock Options as HealthTab PoCT Platform Expands and Tightens Quality Controls2M ago
Company AnnouncementsAvricore’s HealthTab Strikes Landmark UK Point-of-Care Testing Deal with Abbott2M ago
Company AnnouncementsAvricore Health Details June 18 AGM and $1.25 Million Financing in May 2026 SEC Filing4M ago6KCompany AnnouncementsAvricore Health to Roll Out HealthTab Platform Across 70 North East London Pharmacies8M ago6K
Company AnnouncementsAvricore to Expand HealthTab Testing Network Across North East London Pharmacies9M ago
Company AnnouncementsAvricore Health Files Form 6-K With Q3 2025 Interim Results and CEO/CFO Certifications9M ago6K
Company AnnouncementsAvricore Health’s HealthTab™ Powers NHS Pilot for Cholesterol Management10M ago6K
Company AnnouncementsAvricore Health’s HealthTab Expands Role in NHS Cardiovascular Care Pilot11M ago
Company AnnouncementsAvricore Health Expands HealthTab™ to North Central London for NHS Cardiovascular Project1y ago6K
Company AnnouncementsAvricore Health Expands HealthTab™ Platform in NHS Cardiovascular Initiative1y ago
Company AnnouncementsAvricore Health Expands HealthTab Platform Amid Growing Demand for Decentralized Healthcare1y ago
Company AnnouncementsAvricore Health Faces Revenue Challenges Amid Contract Loss1y ago6K
Company AnnouncementsAvricore Health Reports Record Growth and UK Expansion Progress1y ago
Company AnnouncementsAvricore Health Enhances UK Healthcare with HealthTab-PKB Integration1y ago
Company AnnouncementsAvricore Health Shines in Deloitte’s Fast 50 Ranking1y ago6K



